TR200000475T2 - Stafilokok saraların tedavisi. - Google Patents

Stafilokok saraların tedavisi.

Info

Publication number
TR200000475T2
TR200000475T2 TR2000/00475T TR200000475T TR200000475T2 TR 200000475 T2 TR200000475 T2 TR 200000475T2 TR 2000/00475 T TR2000/00475 T TR 2000/00475T TR 200000475 T TR200000475 T TR 200000475T TR 200000475 T2 TR200000475 T2 TR 200000475T2
Authority
TR
Turkey
Prior art keywords
staphylococcal
epilepsy
treatment
glypeptide
palace
Prior art date
Application number
TR2000/00475T
Other languages
English (en)
Inventor
Ioanna Nicas Thalia
Albert Preston David
Lee Zeckel Michael
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200000475T2 publication Critical patent/TR200000475T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Mevcut bulus, düsük glisopeptit hassasiyetli stafilokok sarasinin neden oldugu enfeksiyonlarin tedavisi ile ilgili tedaviye yöneliktir. Bulus, tercihen, Mu50 türü gibi metisiline karsi dirençli olan stafilokok sara türünden saglanir.
TR2000/00475T 1997-08-22 1998-08-18 Stafilokok saraların tedavisi. TR200000475T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5671297P 1997-08-22 1997-08-22

Publications (1)

Publication Number Publication Date
TR200000475T2 true TR200000475T2 (tr) 2000-08-21

Family

ID=22006150

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00475T TR200000475T2 (tr) 1997-08-22 1998-08-18 Stafilokok saraların tedavisi.

Country Status (23)

Country Link
US (1) US5994297A (tr)
EP (1) EP0897725B1 (tr)
JP (1) JP2001513573A (tr)
KR (1) KR100589548B1 (tr)
CN (1) CN1276728A (tr)
AT (1) ATE278413T1 (tr)
AU (1) AU747418B2 (tr)
BR (1) BR9811917A (tr)
CA (1) CA2301589A1 (tr)
CZ (1) CZ299098B6 (tr)
DE (1) DE69826795T2 (tr)
DK (1) DK0897725T3 (tr)
EA (1) EA002602B1 (tr)
ES (1) ES2229454T3 (tr)
HU (1) HU226593B1 (tr)
ID (1) ID24908A (tr)
IL (2) IL134597A0 (tr)
NO (1) NO327042B1 (tr)
NZ (1) NZ502762A (tr)
PT (1) PT897725E (tr)
TR (1) TR200000475T2 (tr)
UA (1) UA59410C2 (tr)
WO (1) WO1999010006A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3006038T (pt) * 2008-08-30 2024-08-23 The Medicines Co Doses únicas de oritavancina para tratamento ou prevenção de uma infeção bacteriana
CN101928331B (zh) * 2009-06-26 2014-05-28 上海来益生物药物研究开发中心有限责任公司 一种化合物及其应用
KR102237887B1 (ko) 2013-03-15 2021-04-07 멜린타 서브시디어리 코프. 항생제를 사용하여 과체중 및 비만 환자에서 감염을 치료하는 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW457248B (en) * 1994-01-28 2001-10-01 Lilly Co Eli Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
KR100589548B1 (ko) 2006-06-15
PT897725E (pt) 2004-12-31
UA59410C2 (uk) 2003-09-15
BR9811917A (pt) 2000-08-15
IL134597A (en) 2007-09-20
DK0897725T3 (da) 2004-12-13
EA002602B1 (ru) 2002-06-27
ES2229454T3 (es) 2005-04-16
EA200000250A1 (ru) 2000-08-28
HUP0002920A2 (hu) 2001-01-29
IL134597A0 (en) 2001-04-30
NZ502762A (en) 2001-10-26
US5994297A (en) 1999-11-30
AU8913798A (en) 1999-03-16
NO20000851D0 (no) 2000-02-21
EP0897725B1 (en) 2004-10-06
JP2001513573A (ja) 2001-09-04
EP0897725A2 (en) 1999-02-24
CZ299098B6 (cs) 2008-04-23
KR20010023108A (ko) 2001-03-26
HU226593B1 (en) 2009-04-28
EP0897725A3 (en) 2000-02-09
CZ2000619A3 (en) 2001-05-16
DE69826795T2 (de) 2005-10-06
NO327042B1 (no) 2009-04-06
DE69826795D1 (de) 2004-11-11
NO20000851L (no) 2000-02-21
HUP0002920A3 (en) 2001-12-28
CA2301589A1 (en) 1999-03-04
ATE278413T1 (de) 2004-10-15
ID24908A (id) 2000-08-31
CN1276728A (zh) 2000-12-13
AU747418B2 (en) 2002-05-16
WO1999010006A1 (en) 1999-03-04

Similar Documents

Publication Publication Date Title
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
DK0986577T3 (da) Opsonisk og beskyttende monoklonale og kimære antistoffer specifikke for lipoteichoicsyre af grampositive bakterier
ATE274499T1 (de) Spiro verbindungen als inhibitoren der fibrinogen-abhängigen blutplättchen aggregation
ATE263157T1 (de) Nematizide trifluorbutene
ATE350044T1 (de) Thrombopoietinmimetika
ATE516062T1 (de) Quaternäre ammoniumverbindungen enthaltende wasserfreie zusammensetzungen
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
CY1108542T1 (el) Εμβολιο πολυσακχαριτη για μολυνσεις απο σταφυλοκοκκο
TR200103119T2 (tr) Göz kurumasının tedavisi için madde.
CY1105482T1 (el) Χρηση της αζιθρομυκινης στην τοπικη αγωγη οφθαλμικων μολυνσεων
DE60207759D1 (de) Pyrimidotriazine als phosphataseinhibitoren
WO2001096606A3 (en) Identification of genes and compounds for treatment of cancer
BR0206697A (pt) Fio tingido espacialmente
TR200002932T2 (tr) Azabisayklik 5HT1 Alıcı liganolları
PT1383947E (pt) Produtos de fibra bioactivos
ATE199321T1 (de) Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen.
TR200000475T2 (tr) Stafilokok saraların tedavisi.
MA27549A1 (fr) N-sulfonyl-4-methylene-amino-3-hydroxy-2-pyridones
TR199800243T1 (tr) Prolil endopeptidaz inhibitörleri.
EA200500353A1 (ru) Производные линкомицина, обладающие антибактериальной активностью
EP1066045A4 (en) Mammalian-derived peptides for the treatment of microbial infection
ATE223226T1 (de) Azazyklohexapeptid-verbindungen
FR2812637B1 (fr) Nouveaux composes derives de dihydroporphyrine et leurs applications
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
ECSP003746A (es) Oxazolidinonas derivadas de sultamas y sultonas